HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
1,166.00
-124.00 (-9.61%)
Nov 20, 2026, 3:30 PM KST
HLB Therapeutics Market Cap
HLB Therapeutics has a market cap or net worth of 102.77 billion as of November 20, 2026. It is the 26,437th most valuable company in the world and the 1,172nd biggest in South Korea. Its market cap has decreased by 61.26% in one year.
Market Cap
102.77B
Enterprise Value
155.04B
Revenue
64.45B
Global Rank
Country Rank
#1,172 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 26, 2010, HLB Therapeutics's market cap has decreased from 105.80B to 102.77B, a decrease of -2.87%. That is a compound annual growth rate of -0.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 102.77B | -59.20% |
| Dec 30, 2025 | 251.87B | -73.05% |
| Dec 30, 2024 | 934.49B | 182.02% |
| Dec 28, 2023 | 331.36B | -9.25% |
| Dec 29, 2022 | 365.14B | -3.64% |
| Dec 30, 2021 | 378.91B | -51.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 198.81B |
| GC Genome | 182.58B |
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| NeoImmuneTech | 139.40B |
| Anterogen.Co.,Ltd. | 129.88B |
| MedPacto | 125.28B |
| Vaxcell-Bio Therapeutics | 81.75B |